Delivery Order SPE2DB24D8001-SPE2DB25FKYXA

Award Date 12/5/24
Potential Completion Date 12/6/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB25FKYXA
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,866.98 firm fixed-price delivery order is for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has a performance period through December 31, 2025 and does not have a set-aside designation.

Generated 3/6/25, 10:04 AM